Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Sep 21, 2023

SELL
$40.9 - $45.1 $2.96 Million - $3.27 Million
-72,400 Reduced 59.15%
50,000 $2.21 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $2.96 Million - $3.27 Million
-72,400 Reduced 59.15%
50,000 $2.22 Million
Q4 2021

Sep 21, 2023

BUY
$38.07 - $44.87 $4.39 Million - $5.18 Million
115,400 Added 1648.57%
122,400 $5.2 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $4.39 Million - $5.18 Million
115,400 Added 1648.57%
122,400 $5.2 Million
Q4 2020

Sep 21, 2023

SELL
$33.15 - $41.97 $1.43 Million - $1.8 Million
-43,000 Reduced 86.0%
7,000 $251,000
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $4.47 Million - $5.48 Million
-129,700 Reduced 94.88%
7,000 $267,000
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $1.9 Million - $2.47 Million
63,100 Added 85.73%
136,700 $4.8 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $1.12 Million - $1.98 Million
43,400 Added 143.71%
73,600 $2.4 Million
Q4 2019

Feb 13, 2020

SELL
$37.87 - $45.37 $1.88 Million - $2.25 Million
-49,600 Reduced 62.16%
30,200 $1.37 Million
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $2.74 Million - $2.95 Million
67,900 Added 570.59%
79,800 $3.25 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $1.33 Million - $1.64 Million
-38,100 Reduced 76.2%
11,900 $511,000
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $3.95 Million - $4.64 Million
-120,200 Reduced 70.62%
50,000 $1.93 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $4.56 Million - $5.83 Million
169,800 Added 42450.0%
170,200 $5.57 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $2.22 Million - $2.67 Million
-89,500 Reduced 99.56%
400 $10,000
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $2.36 Million - $2.62 Million
89,900
89,900 $2.62 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.